The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Carbonic anhydrase inhibitors
Abstract
At least 14 different carbonic anhydrase (CA, EC 4.2.1.1) isoforms were isolated in higher vertebrates, where these zinc enzymes play crucial physiological roles. Some of these isozymes are cytosolic (CA I, CA II, CA III, CA VII), others are membrane‐bound (CA IV, CA IX, CA XII, and CA XIV), CA V is mitochondrial and CA VI is secreted in saliva. Three acatalytic forms are also known, which are denominated CA related proteins (CARP), CARP VIII, CARP X, and CARP XI. Several important physiological and physio‐pathological functions are played by many CA isozymes, which are strongly inhibited by aromatic and heterocyclic sulfonamides as well as inorganic, metal complexing anions. The catalytic and inhibition mechanisms of these enzymes are understood in detail, and this helped the design of potent inhibitors, some of which possess important clinical applications. The use of such enzyme inhibitors as antiglaucoma drugs will be discussed in detail, together with the recent developments that led to isozyme‐specific and organ‐selective inhibitors. A recent discovery is connected with the involvement of CAs and their sulfonamide inhibitors in cancer: several potent sulfonamide inhibitors inhibited the growth of a multitude of tumor cells in vitro and in vivo, thus constituting interesting leads for developing novel antitumor therapies. Furthermore, some other classes of compounds that interact with CAs have recently been discovered, some of which possess modified sulfonamide or hydroxamate moieties. Some sulfonamides have also applications as diagnostic tools, in PET and MRI or as antiepileptics or for the treatment of other neurological disorders. Future prospects for drug design applications for inhibitors of these ubiquitous enzymes are also discussed. © 2002 Wiley Periodicals, Inc. Med Res Rev, 23, No. 2, 146–189, 2003
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Carbonic anhydrase: chemistry, physiology, and inhibition
Maren, T. H. (1967) · Physiological Reviews · doi:10.1152/physrev.1967.47.4.595 · Cited by 1,889
Prokaryotic carbonic anhydrases
Smith, K. (2000) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(00)00030-9 · Cited by 678
Carbonic anhydrase inhibitors and their therapeutic potential
Supuran, C. T., & Scozzafava, A. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.5.575 · Cited by 549
Self-citationCarbonic Anhydrase: Evolution of the Zinc Binding Site by Nature and by Design
Christianson, D. W., & Fierke, C. A. (1996) · Accounts of Chemical Research · doi:10.1021/ar9501232 · Cited by 475
Coleman, J. E. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80064-1 · Cited by 362
Türeci, Ö., Sahin, U., Vollmar, E., Siemer, S., Göttert, E., Seitz, G., Parkkila, A.-K., Shah, G. N., Grubb, J. H., Pfreundschuh, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7608 · Cited by 360
Pastorekova, S., Parkkila, S., Parkkila, A., Opavsky, R., Zelnik, V, Saarnio, J., & Pastorek, J. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024293 · Cited by 351
Multiple Roles of Carbonic Anhydrase in Cellular Transport and Metabolism
Henry, R. P. (1996) · Annual Review of Physiology · doi:10.1146/annurev.ph.58.030196.002515 · Cited by 323
Discovery of Novel Antitumor Sulfonamides Targeting G1 Phase of the Cell Cycle
Owa, T., Yoshino, H., Okauchi, T., Yoshimatsu, K., Ozawa, Y., Sugi, N. H., Nagasu, T., Koyanagi, N., & Kitoh, K. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9902638 · Cited by 322
Cited by
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Supuran, C. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2467 · Cited by 3,192
Self-citationCombination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Interfering with pH regulation in tumours as a therapeutic strategy
Neri, D., & Supuran, C. T. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3554 · Cited by 1,547
Self-citationAlterio, V., Di Fiore, A., D’Ambrosio, K., Supuran, C. T., & De Simone, G. (2012) · Chemical Reviews · doi:10.1021/cr200176r · Cited by 1,238
Self-citationStructure and function of carbonic anhydrases
Supuran, C. T. (2016) · Biochemical Journal · doi:10.1042/bcj20160115 · Cited by 922
Self-citationDrugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Krishnamurthy, V. M., Kaufman, G. K., Urbach, A. R., Gitlin, I., Gudiksen, K. L., Weibel, D. B., & Whitesides, G. M. (2008) · Chemical Reviews · doi:10.1021/cr050262p · Cited by 761
How many carbonic anhydrase inhibition mechanisms exist?
Supuran, C. T. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1122001 · Cited by 737
Self-citationHypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
Švastová, E., Hulı́ková, A., Rafajová, M., Zat'ovičová, M., Gibadulinová, A., Casini, A., Cecchi, A., Scozzafava, A., Supuran, C. T., Pastorek, J., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.043 · Cited by 711
Self-citationPastorekova, S., Parkkila, S., Pastorek, J., & Supuran, C. T. (2004) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360410001689540 · Cited by 662
Self-citationSupuran, C. T. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.05.009 · Cited by 616
Self-citationStructure-based drug discovery of carbonic anhydrase inhibitors
Supuran, C. T. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.672983 · Cited by 614
Self-citationCancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation
Huber, V., Camisaschi, C., Berzi, A., Ferro, S., Lugini, L., Triulzi, T., Tuccitto, A., Tagliabue, E., Castelli, C., & Rivoltini, L. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.001 · Cited by 595
Carbonic anhydrases as targets for medicinal chemistry
Supuran, C. T., & Scozzafava, A. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.04.020 · Cited by 580
Self-citationCarbonic Anhydrases An Overview
Supuran, C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783877884 · Cited by 536
Self-citationNon-Zinc Mediated Inhibition of Carbonic Anhydrases: Coumarins Are a New Class of Suicide Inhibitors
Maresca, A., Temperini, C., Vu, H., Pham, N. B., Poulsen, S.-A., Scozzafava, A., Quinn, R. J., & Supuran, C. T. (2009) · Journal of the American Chemical Society · doi:10.1021/ja809683v · Cited by 521
Self-citationPacchiano, F., Carta, F., McDonald, P. C., Lou, Y., Vullo, D., Scozzafava, A., Dedhar, S., & Supuran, C. T. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101541x · Cited by 519
Self-citationProtease inhibitors of the sulfonamide type: Anticancer, antiinflammatory, and antiviral agents
Supuran, C. T., Casini, A., & Scozzafava, A. (2003) · Medicinal Research Reviews · doi:10.1002/med.10047 · Cited by 431
Self-citationRivera, C., Voipio, J., & Kaila, K. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.077495 · Cited by 428
Capasso, C., & Supuran, C. T. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.910202 · Cited by 406
Self-citationDeciphering the Mechanism of Carbonic Anhydrase Inhibition with Coumarins and Thiocoumarins
Maresca, A., Temperini, C., Pochet, L., Masereel, B., Scozzafava, A., & Supuran, C. T. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901287j · Cited by 402
Self-citationTargeting tumor-associated carbonic anhydrase IX in cancer therapy
Thiry, A., Dogné, J.-M., Masereel, B., & Supuran, C. T. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.09.002 · Cited by 395
Self-citationDrug repurposing and human parasitic protozoan diseases
Andrews, K. T., Fisher, G., & Skinner-Adams, T. S. (2014) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2014.02.002 · Cited by 383
pH control mechanisms of tumor survival and growth
Parks, S. K., Chiche, J., & Pouyssegur, J. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22400 · Cited by 357
Manipulating extracellular tumour pH: an effective target for cancer therapy
Hao, G., Xu, Z. P., & Li, L. (2018) · RSC Advances · doi:10.1039/c8ra02095g · Cited by 341
Del Prete, S., Vullo, D., Fisher, G. M., Andrews, K. T., Poulsen, S.-A., Capasso, C., & Supuran, C. T. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.08.015 · Cited by 326
Self-citationCapasso, C., & Supuran, C. T. (2014) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2013.787422 · Cited by 307
Self-citationPeptide self-assembly triggered by metal ions
Zou, R., Wang, Q., Wu, J., Wu, J., Schmuck, C., & Tian, H. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00234f · Cited by 303
Dependence of Effective Molarity on Linker Length for an Intramolecular Protein−Ligand System
Krishnamurthy, V. M., Semetey, V., Bracher, P. J., Shen, N., & Whitesides, G. M. (2007) · Journal of the American Chemical Society · doi:10.1021/ja066780e · Cited by 294
Structure, function and applications of carbonic anhydrase isozymes
Imtaiyaz Hassan, M., Shajee, B., Waheed, A., Ahmad, F., & Sly, W. S. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.04.044 · Cited by 294
Carbonic Anhydrase Inhibitors and Activators for Novel Therapeutic Applications
Supuran, C. T. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.69 · Cited by 291
Self-citationCarbonic anhydrase IX in oligodendroglial brain tumors
Järvelä, S., Parkkila, S., Bragge, H., Kähkönen, M., Parkkila, A.-K., Soini, Y., Pastorekova, S., Pastorek, J., & Haapasalo, H. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-1 · Cited by 291
Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors
Gümüş, M., Babacan, Ş. N., Demir, Y., Sert, Y., Koca, İ., & Gülçin, İ. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202100242 · Cited by 291
Gitlin, I., Carbeck, J. D., & Whitesides, G. M. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502530 · Cited by 286
Causes, consequences, and therapy of tumors acidosis
Pillai, S. R., Damaghi, M., Marunaka, Y., Spugnini, E. P., Fais, S., & Gillies, R. J. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09792-7 · Cited by 282
Kikutani, S., Nakajima, K., Nagasato, C., Tsuji, Y., Miyatake, A., & Matsuda, Y. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603112113 · Cited by 280
Antiobesity carbonic anhydrase inhibitors: a literature and patent review
Scozzafava, A., Supuran, C. T., & Carta, F. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.790957 · Cited by 273
Self-citationBacterial Carbonic Anhydrases as Drug Targets: Toward Novel Antibiotics?
Supuran, C. T. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00034 · Cited by 267
Self-citationAnticancer carbonic anhydrase inhibitors: a patent review (2008 – 2013)
Monti, S. M., Supuran, C. T., & De Simone, G. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.798648 · Cited by 265
Self-citationAbbate, F., Casini, A., Owa, T., Scozzafava, A., & Supuran, C. T. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.062 · Cited by 262
Self-citationMishra, C. B., Tiwari, M., & Supuran, C. T. (2020) · Medicinal Research Reviews · doi:10.1002/med.21713 · Cited by 260
Self-citationExploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors
De Simone, G., Alterio, V., & Supuran, C. T. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.795145 · Cited by 258
Self-citationStructural annotation of human carbonic anhydrases
Aggarwal, M., Boone, C. D., Kondeti, B., & McKenna, R. (2013) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.737323 · Cited by 257
Medicinal significance of benzothiazole scaffold: an insight view
Sharma, P. C., Sinhmar, A., Sharma, A., Rajak, H., & Pathak, D. P. (2013) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.720572 · Cited by 256
Touisni, N., Maresca, A., McDonald, P. C., Lou, Y., Scozzafava, A., Dedhar, S., Winum, J.-Y., & Supuran, C. T. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200983e · Cited by 253
Self-citationThe Design of Inhibitors for Medicinally Relevant Metalloproteins
Jacobsen, F. E., Lewis, J. A., & Cohen, S. M. (2007) · ChemMedChem · doi:10.1002/cmdc.200600204 · Cited by 132
Ribeiro, A., Sosnik, A., Chiappetta, D. A., Veiga, F., Concheiro, A., & Alvarez-Lorenzo, C. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0102 · Cited by 91
(2023) · doi:10.1126/sciadv.adg6618 · Cited by 67
Innocenti, A., Zimmerman, S., Ferry, J., Scozzafava, A., & Supuran, C. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.073 · Cited by 50
Patel, T. N., Park, A. A., & Banta, S. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24863 · Cited by 38
Metadata
- Authors
- Supuran, C. T., Scozzafava, A., & Casini, A.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2002-12-13
- Volume
- 23
- Issue
- 2
- Pages
- 146-189
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W4211118618
- Cited by
- 1,449
- References
- 65
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.